The use of intravenous immunoglobulin gamma for the treatment of severe coronavirus disease 2019: a randomized placebo-controlled double-blind clinical trial

BACKGROUND: Coronavirus disease 2019 (COVID-19) has infected people in many countries worldwide. Discovering an effective treatment for this disease, particularly in severe cases, has become the subject of intense scientific investigation. Therefore, the objective of this study was to evaluate the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Gharebaghi, Naser, Nejadrahim, Rahim, Mousavi, Seyed Jalil, Sadat-Ebrahimi, Seyyed-Reza, Hajizadeh, Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576972/
https://www.ncbi.nlm.nih.gov/pubmed/33087047
http://dx.doi.org/10.1186/s12879-020-05507-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576972/
https://www.ncbi.nlm.nih.gov/pubmed/33087047
http://dx.doi.org/10.1186/s12879-020-05507-4

Ejemplares similares